STOCK TITAN

Innoviz Technologies Ltd. (INVZ) Financials

INVZ NASDAQ
FY2025 annual
Revenue $55.1M +127.0% YoY
Net Income -$67.8M n/m YoY
EPS (Diluted) -$0.34 n/m YoY
Free Cash Flow -$52.2M n/m YoY
Market Cap $42.9M as of Nov 17, 2026
Price / Sales 0.8x on $55.1M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.6x on $77.7M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INVZ SEC filings page.

Innoviz Technologies Ltd. (INVZ) reported $55.1M in revenue for fiscal year 2025, up 127.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).

Rhea AI INVZ FY2025

Revenue has reached commercial scale, but R&D-heavy operations still consume cash and require outside financing to fund growth.

In FY2025, revenue rose 127.0% while gross margin improved 28.2 percentage points, yet operating loss was $67.7M because R&D was $56.5M—growth is not yet translating into operating break-even. This pairing matters: revenue expansion improved unit economics, but the cost base still absorbs more than gross profit can cover.

Operating cash flow was -$47.9M and free cash flow was -$52.2M, so capital spending added to—not offset—the cash gap. With financing cash flow of $51.5M, that pattern indicates expansion was financed externally rather than by operations.

Liabilities were 43.9% of assets, while the 2.9x current ratio indicates near-term assets exceeded near-term obligations. Equity fell 1.5% from FY2024, while R&D still equaled 102.5% of revenue; the model remains investment-heavy despite improved gross economics.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 55 / 100
Financial Health Score 55/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Innoviz Technologies Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
18

Innoviz Technologies Ltd. held $18.1M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $47.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Innoviz Technologies Ltd. scores 18/100 among other emerging companies.

Dilution
50

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Innoviz Technologies Ltd. scores 50/100 on it among other emerging companies.

R&D Intensity
74

Innoviz Technologies Ltd. spent $56.5M on research and development in fiscal year 2025, which was 46.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Innoviz Technologies Ltd. scores 74/100 among other emerging companies.

Revenue Progress
81

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Innoviz Technologies Ltd. scores 81/100 on it among other emerging companies.

Burn Trend
75

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Innoviz Technologies Ltd. scores 75/100 on it among other emerging companies.

Balance Sheet
34

Innoviz Technologies Ltd.'s cash, cash equivalents and investments came to $18.1M at the end of fiscal year 2025, against $60.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Innoviz Technologies Ltd. scores 34/100 among other emerging companies.

Altman Z-Score Distress
-8.35

Innoviz Technologies Ltd. scores -8.35, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $797.8M against total assets of $138.5M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Innoviz Technologies Ltd. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Innoviz Technologies Ltd. reported a net loss of $67.8M while operations used $47.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
-$0.10
YoYn/m

Innoviz Technologies Ltd. earned -$0.10 per diluted share (EPS) in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Revenue

Not reported for Q4 2025.

EBITDA

Not reported for Q4 2025.

Net Income

Not reported for Q4 2025.

Cash & Balance Sheet

Free Cash Flow
-$10.2M
YoYn/m
QoQn/m

Innoviz Technologies Ltd. recorded an outflow of $10.2M in free cash flow in Q4 2025, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$8.6M
YoY-65.9%
QoQ+9.5%
5Y CAGR-29.6%

Innoviz Technologies Ltd. held $8.6M in cash as of Q4 2025; no long-term debt figure is on record for that period.

Shares Outstanding
214M
YoY+26.4%
QoQ0.0%
5Y CAGR+10.5%

Innoviz Technologies Ltd. had 214M shares outstanding in Q4 2025. This represents an increase of 26.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

Capital Expenditures
$1.0M
YoY-12.7%
QoQ+263.6%

Innoviz Technologies Ltd. invested $1.0M in capex in Q4 2025, funding long-term assets and infrastructure. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is up 263.6%.

R&D Spending

Not reported for Q4 2025.

Share Buybacks

Not reported for Q4 2025.

INVZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVZ quarterly income statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ4'2420-FQ3'246-KQ2'246-KQ4'2320-FQ2'236-K
EPS (Basic)-$0.10n/mN/AN/A-$0.11N/AN/AN/AN/A
EPS (Diluted)-$0.10n/mN/AN/A-$0.11N/AN/AN/AN/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, Diluted Shares (Avg).

INVZ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVZ quarterly balance sheet
MetricQ4'2520-FQ3'256-KQ2'256-KQ4'2420-FQ3'246-KQ2'246-KQ4'2320-FQ2'236-K
Total Assets$138.5M+4.8%$151.1M$151.1M-9.4%$132.0M-39.8%N/A$166.8M-16.1%$219.2M-14.2%$198.8M-35.7%
Current Assets$90.2M+9.2%$102.2M$100.9M-11.8%$82.6M-48.5%N/A$114.4M-12.7%$160.5M-14.4%$131.1M-43.1%
Cash & Equivalents$8.6M-65.9%$7.9M-71.8%$13.5M-43.6%$25.4M-3.5%$27.9M$24.0M-30.1%$26.3M-52.8%$34.3M-31.7%
Short-Term Investments$9.5M-20.8%$9.4Mn/m$9.3M-39.3%$12.0M-10.3%$0$15.3M-38.0%$13.3M-68.0%$24.6M+12.6%
Inventory$3.3M+75.5%$3.0M$3.2M+82.6%$1.9M+2.0%N/A$1.8M-61.8%$1.9M-55.9%$4.6M-1.4%
Accounts Receivable$10.0M+65.1%$19.8M$11.6M+114.5%$6.0M-18.3%N/A$5.4M+127.5%$7.4M+319.7%$2.4M+121.6%
Long-Term Investments$0n/m$0n/m$0-100.0%$0-100.0%$0$1.2M-84.3%$4.8M-38.6%$7.8M-71.3%
Total Liabilities$60.7M+14.3%$61.4M$58.0M+7.2%$53.1M-19.4%N/A$54.1M-12.9%$65.9M+4.0%$62.1M+4.9%
Current Liabilities$31.4M+13.2%$32.1M$28.3M+1.1%$27.8M-25.4%N/A$28.0M-16.1%$37.2M+14.8%$33.4M+20.0%
Non-Current Liabilities$29.3M+15.6%$29.3M$29.7M+13.7%$25.4M-11.7%N/A$26.1M-9.1%$28.7M-7.3%$28.7M-8.5%
Total Equity$77.7M-1.5%$89.7M-3.2%$93.1M-17.4%$78.9M-48.5%$92.6M$112.7M-17.5%$153.3M-20.2%$136.7M-45.3%
Retained Earnings-$797.8Mn/m-$776.6M-$761.2Mn/m-$730.0Mn/mN/A-$686.6Mn/m-$635.3Mn/m-$577.8Mn/m

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

INVZ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVZ quarterly cash flow statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ4'2420-FQ3'246-KQ2'246-KQ4'2320-FQ2'236-K
Operating Cash Flow-$9.1Mn/m-$13.7Mn/mN/A-$17.8M-$16.5MN/AN/AN/A
Depreciation & Amortization$1.8M+12.9%$1.4M-36.9%N/A$1.6M$2.2MN/AN/AN/A
Capital Expenditures$1.0M-12.7%$286K-76.0%N/A$1.2M$1.2MN/AN/AN/A
Free Cash Flow-$10.2Mn/m-$14.0Mn/mN/A-$19.0M-$17.7MN/AN/AN/A
Investing Cash Flow$4.8M-68.4%-$769K-103.8%N/A$15.1M$20.1MN/AN/AN/A
Financing Cash Flow$5.0M+9076.4%$8.9M+15182.8%N/A$55K$58KN/AN/AN/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

INVZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVZ quarterly financial ratios
MetricQ4'2520-FQ3'256-KQ2'256-KQ4'2420-FQ3'246-KQ2'246-KQ4'2320-FQ2'236-K
Current Ratio2.87-0.1x3.183.56-0.5x2.98-1.3xN/A4.09+0.2x4.31-1.5x3.93-4.4x
Liabilities-to-Equity0.78+0.1x0.680.62+0.1x0.67+0.2xN/A0.480.0x0.43+0.1x0.45+0.2x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Innoviz Technologies Ltd. INVZ FY2025 $55.1M -$67.8M N/A $42.9M 55/100
CarParts.com, Inc. PRTS FY2025 $547.5M -$50.4M -9.2% $62.8M 29/100
Microvast Holdings, Inc. MVST FY2025 $427.5M -$29.2M -6.8% $82.0M 41/100
Micware Co., Ltd. MWC FY2026 $140.3M $10.3M 7.3% $77.8M 71/100
Stoneridge, Inc SRI FY2025 $861.3M -$102.8M -11.9% $143.1M 31/100
China Automotive Systems, Inc. CAAS FY2025 $765.7M $42.8M 5.6% $127.6M 54/100

Frequently Asked Questions

Innoviz Technologies Ltd. (INVZ) reported $55.1M in total revenue for fiscal year 2025. This represents a 127.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Innoviz Technologies Ltd. (INVZ) revenue grew by 127.0% year-over-year, from $24.3M to $55.1M in fiscal year 2025.

No, Innoviz Technologies Ltd. (INVZ) reported a net loss of $67.8M in fiscal year 2025.

Innoviz Technologies Ltd. (INVZ) reported diluted earnings per share of -$0.34 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Innoviz Technologies Ltd. (INVZ) had EBITDA of -$61.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Innoviz Technologies Ltd. (INVZ) had a gross margin of 23.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Innoviz Technologies Ltd. (INVZ) has a return on equity of -87.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Innoviz Technologies Ltd. (INVZ) recorded an outflow of $52.2M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Innoviz Technologies Ltd. (INVZ) recorded an outflow of $47.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Innoviz Technologies Ltd. (INVZ) had $138.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Innoviz Technologies Ltd. (INVZ) invested $4.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Innoviz Technologies Ltd. (INVZ) invested $56.5M in research and development during fiscal year 2025.

Innoviz Technologies Ltd. (INVZ) had 214M shares outstanding as of fiscal year 2025.

Innoviz Technologies Ltd. (INVZ) had a current ratio of 2.87 as of fiscal year 2025, which is generally considered healthy.

Innoviz Technologies Ltd. (INVZ) had a liabilities-to-equity ratio of 0.78 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Innoviz Technologies Ltd. (INVZ) had a return on assets of -49.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Innoviz Technologies Ltd. (INVZ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $42.9M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Innoviz Technologies Ltd. (INVZ) trades at 0.8x sales, its market capitalization divided by $55.1M revenue, FY2025. The market capitalization is $42.9M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Innoviz Technologies Ltd. (INVZ) held $18.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $47.9M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Innoviz Technologies Ltd. (INVZ) has an Altman Z-Score of -8.35, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Innoviz Technologies Ltd. (INVZ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Innoviz Technologies Ltd. (INVZ) reported a net loss of $67.8M while operations used $47.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Innoviz Technologies Ltd. (INVZ) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top